v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Net loss $ (9,688,499) $ (10,727,434) $ (21,464,771) $ (24,992,296)
Depreciation expense 24,152 33,724 68,756 95,368
Stock-based compensation expense 383,063 585,484 1,115,154 528,644
Government contract receivable 0 126,638 659,409 (659,409)
Prepaid expenses and other current assets 1,200,111 259,618 (414,544) (352,047)
Accounts payable and accrued expenses 885,349 (578,108) (1,465,596) (412,549)
Total adjustments 2,492,675 427,356 (9,198) 316,785
Net cash used in operating activities (7,195,824) (10,300,078) (21,473,969) (24,675,511)
Purchase of equipment 0 (27,612) (27,612) (20,653)
Net cash used in investing activities 0 (27,612) (27,612) (20,653)
Net proceeds from sale of common stock and warrants 5,272,981 7,914,402 18,924,172 21,398,383
Net proceeds from warrant exercises 1,980,524 209 156,209 2,367,133
Net cash provided by financing activities 7,253,505 7,914,611 19,080,381 23,750,516
Net increase (decrease) in cash and cash equivalents 57,681 (2,413,079) (2,421,200) (945,648)
Cash and cash equivalents at beginning of period 3,085,741 5,506,941 5,506,941 6,452,589
Cash and cash equivalents at end of period $ 3,143,422 $ 3,093,862 $ 3,085,741 $ 5,506,941